What is Gynecomastia? Causes, Diagnosis, and Surgical Correction

Gynecomastia is defined as the benign enlargement of male breast glandular tissue. The term originates from the Greek words gyne (woman) and mastos (breast). Clinical studies suggest that as many as one in three men experience some degree of gynecomastia during their lifetime. It can develop unilaterally (in one breast) or bilaterally, causing significant psychological distress, social inhibition, and aesthetic discomfort.

Clinically, true gynecomastia must be distinguished from pseudogynecomastia (lipomastia or adipomastia), where breast prominence is caused solely by excess subcutaneous fat deposition without proliferative glandular tissue.

What Causes Gynecomastia?

Gynecomastia results primarily from an imbalance between the circulating biological actions of estrogen and testosterone. While both hormones are normally present in both men and women, an absolute or relative elevation in estrogenic stimulation relative to androgenic suppression prompts ductal epithelial hyperplasia and stromal proliferation.

1. Natural Physiological Hormonal Fluctuations

• Neonatal Gynecomastia: More than 60% of newborn males present with palpable breast buds due to transplacental transfer of maternal estrogens. This condition is self-limiting and spontaneously resolves within a few weeks after birth.
• Pubertal Gynecomastia: During early to mid-puberty (ages 12–15), transient hormonal surges and temporary delays in testosterone production compared to estrogen can cause retroareolar swelling and tenderness. In over 90% of adolescents, pubertal gynecomastia regresses spontaneously within 6 to 24 months.
• Senescent / Adult Gynecomastia: Gynecomastia prevalence rises significantly in men aged 50 to 69. With advancing age, circulating free testosterone decreases while peripheral aromatase activity increases, converting circulating androgens into estrogens within expanding adipose depots.

2. Drug-Induced Gynecomastia

Numerous pharmaceutical agents can disrupt the androgen-to-estrogen balance, including:

• Anti-androgens and 5-alpha reductase inhibitors used for benign prostatic hyperplasia (BPH) or prostate cancer (e.g., finasteride, dutasteride, bicalutamide, spironolactone)
• Anabolic-androgenic steroids and testosterone supplements used illicitly for bodybuilding
• Antiretroviral therapies (HAART) utilized in HIV management
• Certain psychiatric medications, including tricyclic antidepressants and anxiolytics
• Cardiovascular agents such as calcium channel blockers (e.g., nifedipine, amlodipine) and digoxin
• Certain cytotoxic chemotherapeutic drugs and antibiotics (e.g., metronidazole, ketoconazole)

3. Recreational Substances and Alcohol

Habitual consumption of certain substances interferes with steroidogenesis and hepatic hormone metabolism:

• Chronic heavy alcohol consumption (leading to impaired hepatic estrogen clearance)
• Amphetamines, cannabis (marijuana), heroin, and methadone

4. Underlying Systemic Medical Conditions

Several medical disorders can precipitate secondary gynecomastia by altering endocrine homeostasis:

• Hypogonadism: Conditions associated with impaired testosterone production, such as Klinefelter syndrome, testicular trauma, or anterior pituitary dysfunction.
• Neoplasms: Endocrine-active tumors of the testes (Leydig or Sertoli cell tumors), adrenal cortex, or pituitary gland.
• Hyperthyroidism: Elevated thyroid hormone stimulates sex hormone-binding globulin (SHBG) synthesis, reducing bioactive free testosterone and elevating bioavailable estrogen.
• Chronic Renal Failure: Gynecomastia is frequently observed in patients undergoing maintenance hemodialysis due to uremic hypogonadism.
• Hepatic Cirrhosis and Liver Failure: Impaired hepatic clearance leads to estrogen accumulation and enhanced peripheral conversion.
• Severe Malnutrition and Refeeding: Prolonged starvation lowers gonadotropin secretion; subsequent refeeding initiates a “second puberty” hormonal surge triggering glandular proliferation.

5. Phytoestrogens and Herbal Formulations

Topical application of products containing essential plant oils—notably tea tree oil and lavender oil—possesses weak intrinsic estrogenic and anti-androgenic activity, which has been linked to prepubertal and adolescent gynecomastia.

Who is at Risk for Gynecomastia?

• Adolescents undergoing active pubertal development
• Aging men over 50 years of age
• Athletes and individuals consuming anabolic steroids, growth hormone, or unregulated fitness supplements
• Patients diagnosed with chronic hepatic, renal, or thyroid disorders, or Klinefelter syndrome

Clinical Symptoms of Gynecomastia

Common clinical manifestations include:

• Palpable enlargement of one or both breasts
• Firm, rubbery, disk-shaped tissue palpable directly behind the nipple-areolar complex
• Localized tenderness, soreness, or hypersensitivity to light touch or friction
• Rarely, nipple discharge (any spontaneous or unilateral serosanguineous discharge warrants immediate diagnostic investigation to rule out male breast malignancy)

How is Gynecomastia Diagnosed?

Diagnostic evaluation begins with a meticulous physical examination. The surgeon palpates the anterior chest wall with the patient supine and upright to distinguish firm, cohesive glandular tissue from soft, diffuse adipose tissue. Further diagnostic workup includes:

• Comprehensive laboratory endocrine panel: serum total and free testosterone, estradiol, LH, FSH, prolactin, beta-hCG, liver enzymes, and renal profile.
• High-resolution bilateral breast ultrasound (USG) to accurately map glandular vs. adipose proportions.
• Bilateral mammography when suspicious, asymmetrical, or eccentric nodules are detected.
• Testicular ultrasonography if an occult testicular tumor is suspected.

Treatment Options for Gynecomastia

Management depends upon duration, etiology, and histological composition:

• Conservative / Medical Management: In recent-onset pubertal cases (less than 12 months) or when secondary to medication, observing watchful waiting or adjusting pharmacological regimens often leads to spontaneous regression. Once fibrosis sets in (usually after 12–24 months), medical therapy becomes largely ineffective.
• Definitive Surgical Intervention: Surgery represents the gold standard, curative treatment for established gynecomastia. Techniques are tailored to the anatomical tissue composition:
  • Glandular Type: Characterized by predominantly dense fibrous gland tissue. Corrected via subcutaneous mastectomy through a discreet semicircular inferior periareolar incision (Webster technique).
  • Fatty Type (Pseudogynecomastia): Characterized by excess adipose tissue. Corrected via ultrasound-assisted (VASER) liposuction through tiny 3 mm micro-incisions.
  • Mixed Type (Most Common): Characterized by combined glandular hyperplasia and surrounding adipose excess. Corrected via high-definition VASER liposuction to contour the chest followed by direct excision of the retroareolar glandular core.
  • Severe Ptotic Gynecomastia (Grade III/IV): In cases with massive glandular excess and lax, redundant skin, gland resection is combined with skin excision to restore a tight, athletic masculine contour.

Pre-Operative Preparation

To ensure patient safety and minimize bleeding complications:

• Discontinue blood-thinning medications, including aspirin, NSAIDs, and anticoagulants, 10 to 14 days before surgery under medical supervision.
• Avoid all herbal teas, multivitamin supplements containing vitamin E, and unregulated fitness boosters for 2 weeks prior to surgery.
• Inform your surgical team about all ongoing medical conditions and prescription medications.
• Refrain from eating or drinking for at least 8 hours prior to general anesthesia.

Post-Operative Recovery and Care

The post-operative recovery period is typically smooth and well-tolerated. When performing modern VASER liposuction with micro-incisions, pain is mild and resembles post-workout muscle soreness. Mild tissue edema and bruising peak within the first 3 to 5 days and resolve over the subsequent 2 to 3 weeks. Patients comfortably return to desk work within 3 to 5 days.

The Gynecomastia Compression Vest

Wearing a medical-grade gynecomastia compression vest is an indispensable component of successful recovery. The garment provides continuous, uniform pressure that limits seroma formation, accelerates lymphatic drainage, minimizes postoperative edema, and ensures that chest skin adheres smoothly to the underlying pectoralis major muscle. Patients wear the compression vest continuously (day and night) for 4 to 6 weeks.

Follow Dr. Sami Samin on Instagram for surgical case studies and clinic updates:
https://www.instagram.com/drsamisamin/
https://www.instagram.com/mamoplastika_baku/